These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34267754)

  • 21. Salivary gland function in Sjögren's syndrome: a review.
    Chisholm DM; Mason DK
    Br Dent J; 1973 Nov; 135(9):393-9. PubMed ID: 4607042
    [No Abstract]   [Full Text] [Related]  

  • 22. Is B-cell the conductor of the lymphocyte orchestra in the salivary glands of patients with primary Sjögren's syndrome.
    Youinou P; Daridon C; Saraux A; Devauchelle V; Pers JO
    Clin Exp Rheumatol; 2006; 24(5):491-2. PubMed ID: 17181915
    [No Abstract]   [Full Text] [Related]  

  • 23. Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sjögren's Syndrome: a retrospective analysis of 65 patients in the Netherlands.
    ter Borg EJ; Risselada AP; Kelder JC
    Semin Arthritis Rheum; 2011 Jun; 40(6):547-51. PubMed ID: 20864144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological and virological studies of cultured labial biopsy cells from patients with Sjögren's syndrome.
    Cremer NE; Daniels TE; Oshiro LS; Marcus F; Claypool R; Sylvester RA; Talal N
    Clin Exp Immunol; 1974 Oct; 18(2):213-24. PubMed ID: 4468195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Salivary gland antibodies in Sjögren's disease].
    Suzuki T; Sakuma H; Imai F; Kawaguchi T
    Nihon Rinsho; 1983; 41(1):206-8. PubMed ID: 6842850
    [No Abstract]   [Full Text] [Related]  

  • 26. Sjogren's syndrome and the danger model.
    Bredberg A; Henriksson G; Larsson A; Manthorpe R; Sallmyr A
    Rheumatology (Oxford); 2005 Aug; 44(8):965-70. PubMed ID: 15840601
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anti-salivary duct antibodies in Sjögren's disease].
    Miyawaki S; Azukizawa H; Kageyama K; Ofuji M
    Nihon Rinsho; 1983; 41(1):208-10. PubMed ID: 6842851
    [No Abstract]   [Full Text] [Related]  

  • 28. Progression of salivary gland dysfunction in patients with Sjogren's syndrome.
    Pijpe J; Kalk WW; Bootsma H; Spijkervet FK; Kallenberg CG; Vissink A
    Ann Rheum Dis; 2007 Jan; 66(1):107-12. PubMed ID: 16728458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in immunopathology of autoimmune diseases in salivary glands.
    Hirokawa K; Kurashima C; Hayashi Y; Sato K; Miyasaka N
    Pathol Immunopathol Res; 1986; 5(3-5):239-47. PubMed ID: 3601873
    [No Abstract]   [Full Text] [Related]  

  • 30. Sjögren's syndrome. Pathogenesis and new approaches to therapy.
    Fox RI
    Adv Exp Med Biol; 1998; 438():891-902. PubMed ID: 9634985
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunohistological studies on T lymphocyte subsets of the salivary glands in Sjögren's syndrome].
    Takaya M; Ichikawa Y; Koriyama K; Shimizu H; Arimori S
    Ryumachi; 1984 Aug; 24(4):250-5. PubMed ID: 6334896
    [No Abstract]   [Full Text] [Related]  

  • 32. Estradiol and testosterone in minor salivary glands of Sjögren's syndrome.
    Kumagami H; Onitsuka T
    Auris Nasus Larynx; 1993; 20(2):137-43. PubMed ID: 8216049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of endothelial barrier function is linked with hyposecretion and lymphocytic infiltration in salivary glands of Sjögren's syndrome.
    Cong X; Zhang XM; Zhang Y; Wei T; He QH; Zhang LW; Hua H; Lee SW; Park K; Yu GY; Wu LL
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3154-3163. PubMed ID: 29981359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polarization of B effector cells in Sjögren's syndrome.
    Daridon C; Guerrier T; Devauchelle V; Saraux A; Pers JO; Youinou P
    Autoimmun Rev; 2007 Aug; 6(7):427-31. PubMed ID: 17643928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B cells expressing CD5 in minor labial salivary glands of patients with primary Sjögren's syndrome.
    Zeher M; Surányi P; Nagy G; Szegedi G
    Arthritis Rheum; 1990 Mar; 33(3):453. PubMed ID: 1690544
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of Novel CD4+ T Cell Subsets in the Target Tissue of Sjögren's Syndrome and Their Differential Regulation by the Lymphotoxin/LIGHT Signaling Axis.
    Haskett S; Ding J; Zhang W; Thai A; Cullen P; Xu S; Petersen B; Kuznetsov G; Jandreski L; Hamann S; Reynolds TL; Allaire N; Zheng TS; Mingueneau M
    J Immunol; 2016 Nov; 197(10):3806-3819. PubMed ID: 27815440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren's syndrome.
    Skarstein K; Jensen JL; Galtung H; Jonsson R; Brokstad K; Aqrawi LA
    Autoimmunity; 2019; 52(7-8):242-250. PubMed ID: 31661985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular-versus-humoral autoimmune responses to salivary gland in Sjögren's syndrome.
    Anderson LG; Tarpley TM; Talal N; Cummings NA; Wolf RO; Schall GL
    Clin Exp Immunol; 1973 Mar; 13(3):335-42. PubMed ID: 4573763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization with 60 kD Ro peptide produces different stages of preclinical autoimmunity in a Sjögren's syndrome model among multiple strains of inbred mice.
    Kurien BT; Dsouza A; Igoe A; Lee YJ; Maier-Moore JS; Gordon T; Jackson M; Scofield RH
    Clin Exp Immunol; 2013 Jul; 173(1):67-75. PubMed ID: 23607771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sjögren's syndrome.
    Shearn MA
    Major Probl Intern Med; 1971; 2():1-262. PubMed ID: 4949970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.